Vicks Sinex Moisturizing 12-Hour Decongestant UltraFine Mist Interactions
There are 51 drugs known to interact with Vicks Sinex Moisturizing 12-Hour Decongestant UltraFine Mist (oxymetazoline nasal), along with 3 disease interactions. Of the total drug interactions, 6 are major, and 45 are moderate.
- View all 51 medications that may interact with Vicks Sinex Moisturizing 12-Hour Decongestant UltraFine Mist
- View Vicks Sinex Moisturizing 12-Hour Decongestant UltraFine Mist disease interactions (3)
Most frequently checked interactions
View interaction reports for Vicks Sinex Moisturizing 12-Hour Decongestant UltraFine Mist (oxymetazoline nasal) and the medicines listed below.
- acetaminophen / hydrocodone
- Advil (ibuprofen)
- albuterol
- amoxicillin
- ashwaganda
- Atrovent (ipratropium)
- azelastine nasal
- Benadryl (diphenhydramine)
- bupropion
- Celebrex (celecoxib)
- cetirizine
- ciprofloxacin
- clonazepam
- cyclobenzaprine
- D3 (cholecalciferol)
- doxycycline
- famotidine
- Flagyl (metronidazole)
- Flonase (fluticasone nasal)
- gabapentin
- guaifenesin
- ibuprofen
- omeprazole
- ondansetron
- prednisone
- Symbicort (budesonide / formoterol)
- trazodone
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Xanax (alprazolam)
Vicks Sinex Moisturizing 12-Hour Decongestant UltraFine Mist disease interactions
There are 3 disease interactions with Vicks Sinex Moisturizing 12-Hour Decongestant UltraFine Mist (oxymetazoline nasal) which include:
More about Vicks Sinex Moisturizing 12-Hour Decongestant UltraFine Mist (oxymetazoline nasal)
- Vicks Sinex Moisturizing 12-Hour Decongestant UltraFine Mist consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: nasal antihistamines and decongestants
- Breastfeeding
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.